Popcorn Lung: the Discovery of a New Disease
This study has been completed.
Sponsor:
National Center for Research Resources (NCRR)
ClinicalTrials.gov Identifier:
NCT00027235
First Posted: November 29, 2001
Last Update Posted: December 9, 2005
Information provided by:
National Center for Research Resources (NCRR)
| Tracking Information | |||
|---|---|---|---|
| First Submitted Date | November 28, 2001 | ||
| First Posted Date | November 29, 2001 | ||
| Last Update Posted Date | December 9, 2005 | ||
| Start Date | Not Provided | ||
| Primary Completion Date | Not Provided | ||
| Current Primary Outcome Measures | Not Provided | ||
| Original Primary Outcome Measures | Not Provided | ||
| Change History | No Changes Posted | ||
| Current Secondary Outcome Measures | Not Provided | ||
| Original Secondary Outcome Measures | Not Provided | ||
| Current Other Outcome Measures | Not Provided | ||
| Original Other Outcome Measures | Not Provided | ||
| Descriptive Information | |||
| Brief Title | Popcorn Lung: the Discovery of a New Disease | ||
| Official Title | Popcorn Lung: the Discovery of a New Disease | ||
| Brief Summary | Recently, an epidemic of pulmonary disease has been recognized among workers in a popcorn factory in Jasper, Missouri. The exposure agent has not yet been identified, but suspects include butter flavoring and the powdered salt used in the mixing room. This disease resembles "Bronchiolitis Obliterans Syndrome", an illness that makes it difficult to breathe. Of the 117 workers studied, one year later, 25 subjects whom were working in the mixing room or in the microwave packaging area have had decreases in lung function seven times the norm for their age. Industrial hygiene experts revealed that dust concentrations of salt and other flavorings were much higher in the mixing room compared to the office and outdoor work areas. Recently, rats were exposed to vapors created by heating the butter flavor compound obtained from this plant. Six-hour exposure to vapors at very high concentration resulted in significant damage to the breathing apparatus. Thus, there is clinical, epidemiological, and animal toxicity data that appears to implicate some constituent present during the mixing of the butter flavoring, salt, and oil causing a form of obstructive airway disease that has been rapidly progressive in a number of workers. It is not clear what the pathophysiologic nature of this entity is, though it resembles Bronchiolitis Obliterans Syndrome. It is not known what the long term consequence of this will be on the active workers, nor is it clear whether preventive measures taken to reduce exposures in the mixing room and elsewhere in the plant are going to be effective. | ||
| Detailed Description | Not Provided | ||
| Study Type | Observational | ||
| Study Design | Observational Model: Defined Population Observational Model: Natural History Time Perspective: Longitudinal |
||
| Target Follow-Up Duration | Not Provided | ||
| Biospecimen | Not Provided | ||
| Sampling Method | Not Provided | ||
| Study Population | Not Provided | ||
| Condition |
|
||
| Intervention | Not Provided | ||
| Study Groups/Cohorts | Not Provided | ||
| Publications * | Not Provided | ||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||
| Recruitment Information | |||
| Recruitment Status | Completed | ||
| Enrollment | Not Provided | ||
| Completion Date | Not Provided | ||
| Primary Completion Date | Not Provided | ||
| Eligibility Criteria | Current employees who have a decline in FEV1 larger than 200cc within the past year will be eligible to participate. All index cases will be eligible to participate. | ||
| Sex/Gender |
|
||
| Ages | 18 Years to 65 Years (Adult) | ||
| Accepts Healthy Volunteers | No | ||
| Contacts | Contact information is only displayed when the study is recruiting subjects | ||
| Listed Location Countries | United States | ||
| Removed Location Countries | |||
| Administrative Information | |||
| NCT Number | NCT00027235 | ||
| Other Study ID Numbers | NCRR-M01RR00036-0829 | ||
| Has Data Monitoring Committee | Not Provided | ||
| U.S. FDA-regulated Product | Not Provided | ||
| IPD Sharing Statement | Not Provided | ||
| Responsible Party | Not Provided | ||
| Study Sponsor | National Center for Research Resources (NCRR) | ||
| Collaborators | Not Provided | ||
| Investigators | Not Provided | ||
| PRS Account | National Center for Research Resources (NCRR) | ||
| Verification Date | December 2003 | ||